Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus.
AUTOR(ES)
Björck, L
RESUMO
Cystatin C is a human cysteine proteinase inhibitor present in extracellular fluids. Cystatin C and a tripeptide derivative (Z-LVG-CHN2) that mimics its proteinase-binding center, were tested for possible antiviral activity against herpes simplex virus type 1 (HSV) and poliovirus type 1. Both recombinant cystatin C and Z-LVG-CHN2 displayed strong inhibitory effects on HSV replication, whereas no significant effect on poliovirus replication was seen. The molar concentration of cystatin C that gave total inhibition of HSV replication was lower than that of either Z-LVG-CHN2 or of acyclovir, the drug currently most used against HSV infections. These results suggest that cysteine proteinase inhibitors might play a physiological role as inhibitors of viral replication and that such proteinase inhibitors, or peptide derivatives that mimic their proteinase-binding centers, might be used as antiviral agents.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=249195Documentos Relacionados
- A human cytomegalovirus function inhibits replication of herpes simplex virus.
- In vitro toxicological evaluation of ISIS 1082, a phosphorothioate oligonucleotide inhibitor of herpes simplex virus.
- Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus.
- Candida albicans produces a cystatin-type cysteine proteinase inhibitor.
- Tromantadine: inhibitor of early and late events in herpes simplex virus replication.
